Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas
University of Chicago
University of Chicago
University of Washington
University of Ulm
BeOne Medicines
Eli Lilly and Company
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
Gilead Sciences
Incyte Corporation
H. Lee Moffitt Cancer Center and Research Institute
University of Washington
University of Washington
Acerta Pharma BV
Universität des Saarlandes
Incyte Corporation
Celgene
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
City of Hope Medical Center
University of Miami
Masonic Cancer Center, University of Minnesota
Janssen Research & Development, LLC
Mayo Clinic
Ohio State University Comprehensive Cancer Center
Fred Hutchinson Cancer Center
National Institutes of Health Clinical Center (CC)
MEI Pharma, Inc.
AstraZeneca
MEI Pharma, Inc.
BeiGene
BeiGene
Genmab
Stanford University
Academic and Community Cancer Research United
University of Rochester
Altor BioScience
City of Hope Medical Center
University of Colorado, Denver
Stanford University
Mayo Clinic
University of Nebraska
University of Nebraska
University of Nebraska
OHSU Knight Cancer Institute
Eastern Cooperative Oncology Group
Ipsen
TG Therapeutics, Inc.
Abramson Cancer Center at Penn Medicine
M.D. Anderson Cancer Center
Atara Biotherapeutics